(Q84893829)
Statements
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma (English)
Bob Lanier
Tracy Bridges
Angel Fowler Taylor
Indrias Berhane
Carlos Fernandez Vidaurre
1 December 2009